Telix Pharmaceuticals Limited Unsponsored ADR(TLX)
$9.36-0.37 (-3.75%)
TLX
Telix Pharmaceuticals Limited Unsponsored ADR earnings date
$9.36
At close:-0.37 (-3.75%)
Want to see TLX full AI Analyst Report?
Telix Pharmaceuticals Limited Unsponsored ADR (TLX) Q2 2022 Earnings Report
14 Followers
TLX Q2 2022 EPS Results
- Actual EPS
- -$0.16
- Consensus EPS
- -$0.08
- Beat/Miss
- Missed by -$0.08
- One Year Ago EPS
- -$0.08
TLX Q2 2022 Revenue Results
- Actual Revenue
- $17.28M
- Expected Revenue
- $15.52M
- Beat/Miss
- Beat by +$1.76M
- YoY Revenue Growth
- +669.93%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/17/2022
- Time
- After Close
- Conference Call
- Wednesday, August 17, 2022
TLX Upcoming Earnings
Telix Pharmaceuticals Limited Unsponsored ADR's next earnings date is estimated for February 19, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
TLX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 19, 2027 | 2026 (Q4) | 0.06- | -0.01 | ― | ― |
| Aug 19, 2026 | 2026 (Q2) | 0.020.17 | 0.01 | 1600.00% (+0.16) | |
| Feb 19, 2026 | 2025 (Q4) | 0.04-0.01 | 0.04 | -131.58% (-0.05) | |
| Aug 20, 2025 | 2025 (Q2) | 0.180.01 | 0.06 | -83.61% (-0.05) | |
| Feb 20, 2025 | 2024 (Q4) | 0.040.04 | 0.04 | 2.70% (+0.00) | |
| Aug 22, 2024 | 2024 (Q2) | 0.100.06 | -0.03 | 310.34% (+0.09) | |
| Feb 22, 2024 | 2023 (Q4) | 0.050.04 | -0.02 | 331.25% (+0.05) | |
| Aug 23, 2023 | 2023 (Q2) | 0.04-0.03 | -0.16 | 81.88% (+0.13) | |
| Feb 27, 2023 | 2022 (Q4) | -0.05-0.02 | -0.12 | 86.67% (+0.10) | |
| Aug 17, 2022 | 2022 (Q2) | -0.08-0.16 | -0.08 | -92.77% (-0.08) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
